Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06225167 · ClinicalTrials.gov registry record
Pharmacist-Driven Stress Ulcer Prophylaxis Minimization in the Intensive Care Unit
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 120
- Enrollment target
NCT06225167 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 120 participants.
The verdict
NCT06225167 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
Pharmacologic stress ulcer prophylaxis is routinely used in the intensive care unit (ICU) to prevent upper gastrointestinal (GI) bleeding in critically ill patients.
Interventions
- BEHAVIORAL To evaluate the effectiveness and safety of a pharmacist-driven protocol to discontinue stress ulcer prophylaxis in ICU patients when it is no longer indicated according to pre-defined criteria.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-05-13 |
| Est. Completion | 2023-07-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06225167
The ClinicalTrials.gov registry entry for NCT06225167 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which To evaluate the effectiveness and safety of a pharmacist-driven protocol to discontinue stress ulcer prophylaxis in ICU patients when it is no longer indicated according to pre-defined criteria. is the first listed.
NCT06225167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06225167 about?
NCT06225167 is a clinical study titled "Pharmacist-Driven Stress Ulcer Prophylaxis Minimization in the Intensive Care Unit". Pharmacologic stress ulcer prophylaxis is routinely used in the intensive care unit (ICU) to prevent upper gastrointestinal (GI) bleeding in critically ill patients.
What is the current status of trial NCT06225167?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2023-05-13. Estimated completion is 2023-07-17.
What interventions are being tested in trial NCT06225167?
The interventions under investigation include: To evaluate the effectiveness and safety of a pharmacist-driven protocol to discontinue stress ulcer prophylaxis in ICU patients when it is no longer indicated according to pre-defined criteria. (BEHAVIORAL).
Who is sponsoring clinical trial NCT06225167?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.